Dr. Merrill Garnett, a doctor and research chemist, is the founder and CEO of Garnett McKeen Laboratory, Inc. in Stony Brook, New York. He is the inventor and recipient of three U.S. patents for Poly-MVA.

Dr. Garnett holds a D.D.S. from the New York University and has received graduate education in Chemistry and Biochemistry. He has had research laboratories at the Central Islip State Hospital, Waldemar Medical Research Foundation, Northport Veterans' Administration Medical Center, and the High Technology Incubator of The State University of New York at Stony Brook.

Dr. Garnett's principle laboratory discoveries reveal the presence of corollary dynamics of the genetic code by which specific DNA coded segments and cell membranes exchange ultra-low frequency sinusoidal electrical currents. According to his theory, these pulsed currents are the basis of all physiological pulses and determine the polarization, charge and folding of enzymes, nucleic acids and membrane phospholipids. The restoration of these charge transfer pathways form the basis of several new methods of medicinal management.

Following his revolutionary dream for a safe and effective treatment for cancer, Dr. Garnett invested 40 years to probing the secrets of molecular biology and the mysteries of cells. He saw cancer as the failure of cells to regenerate normally in a default mode; instead, cloning itself within the cancer mechanism over and over again. He decided this failure to mature was a problem of energetics in the cell's metabolic processes.

Dr. Garnett sought for a molecular compound that would restore healthy pathways for growth and normal development within the cell— pathways missing in the cancer cells. He searched for a metallo-organic compound that would aid in the restoration of the cell's healthy energetics.

Thus far, Dr. Garnett has been issued three United States patents related to the treatment of tumors and psoriasis.